MedTrace Logo

Effects of LDX on Functioning of College Students With ADHD

NCT01342445 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to evaluate the effects of lisdexamfetamine dimesylate, a prodrug stimulant, on the behavioral, academic, and psychosocial functioning of college students with attention-deficit/hyperactivity disorder (ADHD). Twenty-five college students with ADHD from two universities (University of Rhode Island and Lehigh University) completed a within-subject, placebo-controlled research trial. Dependent measures tapping behavioral, psychosocial, and academic functioning were completed on a weekly basis across five conditions (baseline, placebo, and 30-mg, 50-mg, and 70-mg lisdexamfetamine).

Conditions

  • Attention-deficit/Hyperactivity Disorder

Interventions

DRUG

lisdexamfetamine dimesylate

30-mg, 50-mg, 70-mg administered for one week in context of double-blind, placebo-controlled crossover design

DRUG

Placebo

Sponsors & Collaborators

  • Lehigh University

    collaborator OTHER

  • University of Rhode Island

    lead OTHER

Principal Investigators

  • Lisa L Weyandt, PhD · University of Rhode Island

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01342445 on ClinicalTrials.gov